Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: Implications for cancer therapy

Expert Reviews in Molecular Medicine

Volumn 17, Issue , 2015, Pages

  Pandolfi, Silvia ^a   Stecca, Barbara ^a,b  

^a ISTITUTO TOSCANO TUMORI   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (8 CYCLOPENTYL 7 ETHYL 5,6,7,8 TETRAHYDRO 5 METHYL 6 OXO 2 PTERIDINYLAMINO) 3 METHOXY N (1 METHYL 4 PIPERIDINYL)BENZAMIDE; BEVACIZUMAB; BMS 833923; BUPARLISIB; CETUXIMAB; CYCLOPAMINE; DACTOLISIB; DOCETAXEL; ERLOTINIB; EVEROLIMUS; GEFITINIB; GEMCITABINE; GLASDEGIB; NILOTINIB; PATIDEGIB; PLACEBO; PONATINIB; PROTEIN PATCHED; RAPAMYCIN; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; SONIDEGIB; TALADEGIB; TEMOZOLOMIDE; TOZASERTIB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI; UNCLASSIFIED DRUG; UNINDEXED DRUG; VISMODEGIB; GLI1 PROTEIN, HUMAN; LIGAND;

ACUTE LEUKEMIA; ADVANCED CANCER; ADVERSE OUTCOME; AGEUSIA; ALOPECIA; ANTIPROLIFERATIVE ACTIVITY; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BILE DUCT CARCINOMA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER STEM CELL; CANCER THERAPY; CARCINOGENICITY; CHONDROSARCOMA; CHRONIC MYELOID LEUKEMIA; COLON CANCER; COLORECTAL CANCER; DECREASED APPETITE; DEHYDRATION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DYSGEUSIA; ESOPHAGEAL ADENOCARCINOMA; FATIGUE; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LUNG CANCER; MEDULLOBLASTOMA; MELANOMA; MENINGIOMA; MOLECULAR INTERACTION; MULTIPLE MYELOMA; MUSCLE CRAMP; MUSCLE SPASM; MUTATIONAL ANALYSIS; MYALGIA; NAUSEA; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECOMMENDED DRUG DOSE; REGULATORY MECHANISM; REVIEW; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; SOLID TUMOR; ANTAGONISTS AND INHIBITORS; CELL TRANSFORMATION; DRUG EFFECTS; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY;

CELL TRANSFORMATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; LIGANDS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84927751287     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/erm.2015.3     Document Type: Review

References (300)

1. Ingham, P.W. and McMahon, A.P. (2001) Hedgehog signaling in animal development: paradigms and principles. Genes & Development 15, 3059-3087
2. Briscoe, J. and Therond, P.P. (2013) The mechanisms of Hedgehog signalling and its roles in development and disease. Nature Reviews Molecular Cell Biology 14, 416-429
3. Teperino, R. et al. (2012) Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. Cell 151, 414-426
4. Courchet, J. and Polleux, F. (2012) Sonic hedgehog, BOC, and synaptic development: new players for an old game. Neuron 73, 1055-1058
5. Babcock, D.T. et al. (2011) Hedgehog signaling regulates nociceptive sensitization. Current Biology 21, 1525-1533
6. Teglund, S. and Toftgard, R. (2010) Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochimica et Biophysica Acta 1805, 181-208
7. Stecca, B. and Ruiz i Altaba, A. (2010) Contextdependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. Journal of Molecular Cell Biology 2, 84-95
8. Nusslein-Volhard, C. and Wieschaus, E. (1980) Mutations affecting segment number and polarity in Drosophila. Nature 287, 795-801
9. Rohatgi, R., Milenkovic, L. and Scott, M.P. (2007) Patched1 regulates hedgehog signaling at the primary cilium. Science 317, 372-376
10. Eggenschwiler, J.T. and Anderson, K.V. (2007) Cilia and developmental signaling. Annual Review of Cell and Developmental Biology 23, 345-373
11. Wong, S.Y. and Reiter, J.F. (2008) The primary cilium at the crossroads of mammalian hedgehog signaling. Current Topics in Developmental Biology 85, 225-260
12. Rohatgi, R. and Scott, M.P. (2007) Patching the gaps in Hedgehog signalling. Nature Cell Biology 9, 1005-1009
13. Jiang, J. and Hui, C.C. (2008) Hedgehog signaling in development and cancer. Developmental Cell 15, 801-812
14. Varjosalo, M. and Taipale, J. (2008) Hedgehog: functions and mechanisms. Genes & Development 22, 2454-2472
15. Wang, B., Fallon, J.F. and Beachy, P.A. (2000) Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100, 423-434
16. Pan, Y. et al. (2006) Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Molecular and Cellular Biology 26, 3365-3377
17. Dai, P. et al. (1999) Sonic Hedgehog-induced activation of the Gli1 promoter ismediated by GLI3. Journal of Biological Chemistry 274, 8143-8152
18. Bai, C.B., Stephen, D. and Joyner, A.L. (2004) All mouse ventral spinal cord patterning by hedgehog is Gli dependent and involves an activator function of Gli3. Developmental Cell 6, 103-115
19. Lee, J. et al. (1997) Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 124, 2537-2552
20. Milla, L.A., Gonzalez-Ramirez, C.N. and Palma, V. (2012) Sonic Hedgehog in cancer stemcells: a novel linkwithautophagy. BiologicalResearch45, 223-230
21. Kinzler, K.W. and Vogelstein, B. (1990) The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Molecular and Cellular Biology 10, 634-642
22. Winklmayr, M. et al. (2010) Non-consensus GLI binding sites in Hedgehog target gene regulation. BMC Molecular Biology 11, 2
23. Ikram, M.S. et al. (2004)GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. Journal of Investigative Dermatology 122, 1503-1509
24. Wang, X.Q. and Rothnagel, J.A. (2001) Posttranscriptional regulation of the gli1 oncogene by the expression of alternative 5′ untranslated regions. Journal of Biological Chemistry 276, 1311-1316
25. Shimokawa, T. et al. (2013)RNAediting of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biology 10, 321-333
26. Dunaeva, M. et al. (2003) Characterization of the physical interaction of Gli proteins with SUFU proteins. Journal of Biological Chemistry 278, 5116-5122
27. Merchant, M. et al. (2004) Suppressor of fused regulates Gli activity through a dual binding mechanism. Molecular and Cellular Biology 24, 8627-8641
28. Cherry, A.L. et al. (2013) Structural basis of SUFUGLI interaction in human Hedgehog signalling regulation. Acta Crystallographica Section D: Biological Crystallography 69, 2563-2579
29. Ding, Q. et al. (1999) Mouse suppressor of fused is a negative regulator of sonic hedgehog signaling and alters the subcellular distribution of Gli1. Current Biology 9, 1119-1122
30. Barnfield, P.C. et al. (2005) Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms. Differentiation 73, 397-405
31. Huntzicker, E.G. et al. (2006) Dual degradation signals control Gli protein stability and tumor formation. Genes & Development 20, 276-281
32. Di Marcotullio, L. et al. (2006) Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nature Cell Biology 8, 1415-1423
33. Mazza, D. et al. (2013) PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress. Cell Death and Differentiation 20, 1688-1697
34. Malatesta, M. et al. (2013) Histone acetyltransferase PCAF is required for Hedgehog-Gli-dependent transcription and cancer cell proliferation. Cancer Research 73, 6323-6333
35. Gilder, A.S. et al. (2013) Fem1b promotes ubiquitylation and suppresses transcriptional activity of Gli1. Biochemical and Biophysical Research Communications 440, 431-436
36. Canettieri, G. et al. (2010) Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Nature Cell Biology 12, 132-142
37. Maloverjan, A. et al. (2010) Dual function of UNC-51-like kinase 3 (Ulk3) in the Sonic hedgehog signaling pathway. Journal of Biological Chemistry 285, 30079-30090
38. Sheng, T. et al. (2006) Regulation ofGli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal. Journal of Biological Chemistry 281, 9-12
39. Asaoka, Y. et al. (2010) Identification of a suppressive mechanism for Hedgehog signaling through a novel interaction of Gli with 14-3-3. Journal of Biological Chemistry 285, 4185-4194
40. Atwood, S.X. et al. (2013) GLI activation byatypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas. Nature 494, 484-488
41. Wang, Y. et al. (2012) The crosstalk of mTOR/ S6K1 and Hedgehog pathways. Cancer Cell 21, 374-387
42. Mao, J. et al. (2002) Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. Journal of Biological Chemistry 277, 35156-35161
43. Varjosalo, M. et al. (2008) Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 133, 537-548
44. Ruiz i Altaba, A. (1999) Gli proteins encode context-dependent positive and negative functions: implications for development and disease. Development 126, 3205-3216
45. Niewiadomski, P. et al. (2014) Gli protein activity is controlled by multisite phosphorylation in vertebrate Hedgehog signaling. Cell Reports 6, 168-181
46. Bhatia, N. et al. (2006) Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase. Journal of Biological Chemistry 281, 19320-19326
47. Liu, Z. et al. (2014) MEK1-RSK2 contributes to Hedgehog signaling by stabilizing GLI2 transcription factor and inhibiting ubiquitination. Oncogene 33, 65-73
48. Wang, C., Pan, Y. and Wang, B. (2010) Suppressor of fusedandSpopregulate the stability, processingand function of Gli2 and Gli3 full-length activators but not their repressors. Development 137, 2001-2009
49. Li, Z.J. et al. (2012) Kif7 regulates Gli2 through Sufu-dependent and-independent functions during skin development and tumorigenesis. Development 139, 4152-4161
50. Cheung, H.O. et al. (2009) The kinesin protein Kif7 is a critical regulator of Gli transcription factors in mammalianhedgehog signaling. Science Signaling 2, ra29
51. Han, L., Pan, Y. and Wang, B. (2012) Small ubiquitin-like Modifier (SUMO) modification inhibits GLI2 protein transcriptional activity in vitro and in vivo. Journal of Biological Chemistry 287, 20483-20489
52. Coni, S. et al. (2013) Gli2 acetylation at lysine 757 regulates hedgehog-dependent transcriptional output by preventing its promoter occupancy. PLoS ONE 8, e65718
53. Tempe, D. et al. (2006) Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Molecular and Cellular Biology 26, 4316-4326
54. Wang, B. and Li, Y. (2006) Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing.Proceedings of theNationalAcademyof Sciences of the United States of America 103, 33-38
55. Endoh-Yamagami, S. et al. (2009) The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development. Current Biology 19, 1320-1326
56. Dai, P. et al. (2002) Ski is involved in transcriptional regulation by the repressor and full-length forms of Gli3. Genes & Development 16, 2843-2848
57. Scales, S.J. and de Sauvage, F.J. (2009) Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends in Pharmacological Sciences 30, 303-312
58. Gorlin, R.J. (1995) Nevoid basal cell carcinoma syndrome. Dermatologic Clinics 13, 113-125
59. Hahn, H. et al. (1996) A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. Journal of Biological Chemistry 271, 12125-12128
60. Johnson, R.L. et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-1671
61. Taylor, M.D. et al. (2002) Mutations in SUFU predispose to medulloblastoma. Nature Genetics 31, 306-310
62. Sheng, T. et al. (2004) Activation of the hedgehog pathway in advanced prostate cancer. Molecular Cancer 3, 29
63. Di Marcotullio, L. et al. (2004) REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America 101, 10833-10838
64. Xie, J. et al. (1998)ActivatingSmoothenedmutations in sporadic basal-cell carcinoma. Nature 391, 90-92
65. Kinzler, K.W. et al. (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236, 70-73
66. Northcott, P.A. et al. (2009) Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nature Genetics 41, 465-472
67. Varnat, F. et al. (2009) Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Molecular Medicine 1, 338-351
68. Watkins, D.N. et al. (2003) Hedgehog signalling within airway epithelial progenitors and in smallcell lung cancer. Nature 422, 313-317
69. Yuan, Z. et al. (2007) Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene 26, 1046-1055
70. Thayer, S.P. et al. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856
71. Feldmann, G. et al. (2007) Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Research 67, 2187-2196
72. Berman, D.M. et al. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846-851
73. Karhadkar, S.S. et al. (2004) Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707-712
74. Sanchez, P. et al. (2004) Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proceedings of the National Academy of Sciences of the United States of America 101, 12561-12566
75. Clement, V. et al. (2007) HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Current Biology 17, 165-172
76. Bar, E.E. et al. (2007) Hedgehog signaling promotes medulloblastoma survival via BclII. American Journal of Pathology 170, 347-355
77. Ehtesham, M. et al. (2007) Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene 26, 5752-5761
78. Stecca, B. et al. (2007) Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proceedings of the National Academy of Sciences of the United States of America 104, 5895-5900
79. Yauch, R.L. et al. (2008) A paracrine requirement for hedgehog signalling in cancer. Nature 455, 406-410
80. Mills, L.D. et al. (2013) Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation. Journal of Biological Chemistry 288, 11786-11794
81. Becher, O.J. et al. (2008) Gli activity correlates with tumor grade in platelet-derived growth factorinduced gliomas. Cancer Research 68, 2241-2249
82. Dierks, C. et al. (2007) Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nature Medicine 13, 944-951
83. Hegde, G.V. et al. (2008) Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Molecular Cancer Therapeutics 7, 1450-1460
84. Bar, E.E. et al. (2007) Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25, 2524-2533
85. Fu, J. et al. (2013) NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Neuro-Oncology 15, 691-706
86. Liu, S. et al. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Research 66, 6063-6071
87. Feldmann, G. et al. (2008) An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Molecular Cancer Therapeutics 7, 2725-2735
88. Peacock, C.D. et al. (2007) Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America 104, 4048-4053
89. Dierks, C. et al. (2008) ExpansionofBcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14, 238-249
90. Zhao, C. et al. (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776-779
91. Lin, T.L. et al. (2010) Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS ONE 5, e15262
92. Santini, R. et al. (2012) Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells 30, 1808-1818
93. Schiapparelli, P. et al. (2011) Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+cell compartment and the in vitro tumorigenic capability of neuroblastoma cells. Cancer Letters 310, 222-231
94. Po, A. et al. (2010) Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO Journal 29, 2646-2658
95. Zbinden, M. et al. (2010)NANOGregulates glioma stem cells and is essential in vivo acting in a crossfunctional network with GLI1 and p53. EMBO Journal 29, 2659-2674
96. Takanaga, H. et al. (2009) Gli2 is a novel regulator of sox2 expression in telencephalic neuroepithelial cells. Stem Cells 27, 165-174
97. Ahlfeld, J. et al. (2013) Sox2 requirement in sonic hedgehog-associated medulloblastoma. Cancer Research 73, 3796-3807
98. Santini, R. et al. (2014) SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene 33, 4697-4708
99. Gailani, M.R. et al. (1996) The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genetics 14, 78-81
100. Reifenberger, J. et al. (2005) Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. British Journal of Dermatology 152, 43-51
101. Pietsch, T. et al. (1997) Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Research 57, 2085-2088
102. Raffel, C. et al. (1997) Sporadic medulloblastomas contain PTCH mutations. Cancer Research 57, 842-845
103. Wolter, M. et al. (1997) Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Research 57, 2581-2585
104. Reifenberger, J. et al. (1998) Missense mutations in SMOH in sporadic basal cell carcinomas of the skin andprimitiveneuroectodermal tumorsof thecentral nervous system. Cancer Research 58, 1798-1803
105. Northcott, P.A. et al. (2011) Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathologica 122, 231-240
106. Ferretti, E. et al. (2005) Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm.Trends inMolecularMedicine11,537-545
107. Goodrich, L.V. et al. (1997) Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-1113
108. Hahn, H. et al. (1998) Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nature Medicine 4, 619-622
109. Aszterbaum, M. et al. (1999) Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nature Medicine 5, 1285-1291
110. Epstein, E.H. (2008) Basal cell carcinomas: attack of the hedgehog. Nature Reviews Cancer 8, 743-754
111. Hui, A.B. et al. (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Laboratory Investigation 81, 717-723
112. Mao, X. and Hamoudi, R.A. (2000) Molecular and cytogenetic analysis of glioblastoma multiforme. Cancer Genetics and Cytogenetics 122, 87-92
113. Frattini, V. et al. (2013) The integrated landscape of driver genomic alterations in glioblastoma. Nature Genetics 45, 1141-1149
114. Du, W. et al. (2015) Targeting theSMOoncogene by miR-326 inhibits glioma biological behaviors and stemness. Neuro-Oncology 17, 243-253
115. O'Toole, S.A. et al. (2011) Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Research 71, 4002-4014
116. Jeng, K.S. et al. (2013) High expression of Sonic Hedgehog signaling pathway genes indicates a risk of recurrence of breast carcinoma. Journal of OncoTargets and Therapy 7, 79-86
117. ten Haaf, A. et al. (2009) Expression of the gliomaassociated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer 9, 298
118. Fiaschi, M. et al. (2009) Development of mammary tumors by conditional expression of GLI1. Cancer Research 69, 4810-4817
119. Naylor, T.L. et al. (2005) High resolution genomic analysis of sporadic breast cancer using arraybased comparative genomic hybridization. Breast Cancer Research 7, R1186-R1198
120. Nessling, M. et al. (2005) Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Research 65, 439-447
121. Kubo, M. et al. (2004) Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Research 64, 6071-6074
122. Wolf, I. et al. (2007) Unmasking of epigenetically silenced genes revealsDNApromoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Research and Treatment 105, 139-155
123. Cui, W. et al. (2010) Expression and regulation mechanisms of Sonic Hedgehog in breast cancer. Cancer Science 101, 927-933
124. Caserta, T.M. et al. (2006) p63 overexpression induces the expression of Sonic Hedgehog. Molecular Cancer Research 4, 759-768
125. Pratap, J. et al. (2008) Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Research 68, 7795-7802
126. Sun, Y. et al. (2014) Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation. Molecular Cancer 13, 137
127. Ramaswamy, B. et al. (2012) Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3 K/AKT pathway. Cancer Research 72, 5048-5059
128. Mukherjee, S. et al. (2006) Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biology & Therapy 5, 674-683
129. Harris, L.G. et al. (2012) Increased vascularity and spontaneous metastasis of breast cancer byhedgehog signaling mediated upregulation of cyr61. Oncogene 31, 3370-3380
130. Cao, X. et al. (2012) Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene 31, 104-115
131. Fokas, E. et al. (2014) Pancreatic ductal adenocarcinoma: from genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic. Biochimica et Biophysica Acta 1855, 61-82
132. Jones, S. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806
133. Hebrok, M. et al. (2000) Regulation of pancreas development by hedgehog signaling. Development 127, 4905-4913
134. Morton, J.P. et al. (2007) Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 104, 5103-5108
135. Tian, H. et al. (2009) Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 106, 4254-4259
136. Li, X. et al. (2014) Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer. Clinical Cancer Research 20, 4326-4338
137. Bailey, J.M., Mohr, A.M. and Hollingsworth, M.A. (2009) Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28, 3513-3525
138. Bailey, J.M. et al. (2008) Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clinical Cancer Research 14, 5995-6004
139. Olive, K.P. et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461
140. Rhim, A.D. et al. (2014) Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735-747
141. Lee, J.J. et al. (2014) Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proceedings of the National Academy of Sciences of the United States of America 111, E3091-E3100
142. Fan, L. et al. (2004) Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145, 3961-3970
143. Wilkinson, S.E. et al. (2013) Hedgehog signaling is active in human prostate cancer stroma and regulates proliferation and differentiation of adjacent epithelium. Prostate 73, 1810-1823
144. Shigemura, K. et al. (2011) Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells. Prostate 71, 1711-1722
145. Azoulay, S. et al. (2008) Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression. The Journal of Pathology 216, 460-470
146. Thiyagarajan, S. et al. (2007) Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Research 67, 10642-10646
147. Narita, S. et al. (2008) GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgenindependent prostate cancer. Clinical Cancer Research 14, 5769-5777
148. Efstathiou, E. et al. (2013) Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. Prostate 73, 153-161
149. Chen, M. et al. (2009) Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells. Cell Cycle 8, 149-157
150. Chen, M. et al. (2010) Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells. Molecular Cancer 9, 89
151. Krauthammer, M. et al. (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nature Genetics 44, 1006-1014
152. O'Reilly, K.E. et al. (2013) Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo. Pharmaceuticals 6, 1429-1450
153. Jalili, A. et al. (2013) NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo. PLoS ONE 8, e69064
154. Alexaki, V.I. et al. (2010) GLI2-mediated melanoma invasion and metastasis. Journal of the National Cancer Institute 102, 1148-1159
155. Das, S. et al. (2009) The hedgehog pathway transcription factor GLI1 promotes malignant behaviorofcancercellsbyup-regulatingosteopontin. Journal of Biological Chemistry 284, 22888-22897
156. Xu, M. et al. (2012) Prognostic value of hedgehog signaling pathway in patients with colon cancer. Medical Oncology 29, 1010-1016
157. Wang, Z.C. et al. (2013) Aberrant expression of sonic hedgehog pathway in colon cancer and melanosis coli. Journal of Digestive Diseases 14, 417-424
158. Mazumdar, T. et al. (2011) The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Oncotarget 2, 638-645
159. Lee, S.Y. et al. (2007) Sonic hedgehog expression in gastric cancer and gastric adenoma. Oncology Reports 17, 1051-1055
160. Yoo, Y.A. et al. (2011) Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Research 71, 7061-7070
161. Saze, Z. et al. (2012) Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer. Digestive Surgery 29, 115-123
162. Niu, Y. et al. (2014) Clinicopathological correlation and prognostic significance of sonic hedgehog protein overexpression in human gastric cancer. International Journal of Clinical and Experimental Pathology 7, 5144-5153
163. Wang, Z.S. et al. (2014) Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer. Tumor Biology 35, 1357-1363
164. Wang, X.D. et al. (2013) Mutations in the hedgehog pathway genes SMO and PTCH1 in human gastric tumors. PLoS ONE 8, e54415
165. Zuo, Y. and Song, Y. (2013) Detection and analysis of the methylation status of PTCH1 gene involved in the hedgehog signaling pathway in a human gastric cancer cell line. Experimental and Therapeutic Medicine 6, 1365-1368
166. Song, Y. et al. (2013) Altered expression of PTCH and HHIP in gastric cancer through their gene promoter methylation: novel targets for gastric cancer. Molecular Medicine Reports 7, 1159-1168
167. Seto, M. et al. (2009) Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer. Molecular Carcinogenesis 48, 703-712
168. Han, M.E. et al. (2009) Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of Bcl-2. International Journal of Molecular Sciences 10, 3033-3043
169. Wan, J. et al. (2014) Sonic hedgehog pathway contributes to gastric cancer cell growth and proliferation. BioResearch Open Access 3, 53-59
170. Yoon, C. et al. (2014) CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. Clinical Cancer Research 20, 3974-3988
171. Song, Z. et al. (2011) Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS ONE 6, e17687
172. Gialmanidis, I.P. et al. (2009) Overexpression of hedgehog pathway molecules and FOXM1 in nonsmall cell lung carcinomas. Lung Cancer 66, 64-74
173. Hong, Z. et al. (2014) Activation of Hedgehog Signaling Pathway inHumanNon-small Cell Lung Cancers. Pathology & Oncology Research 20, 917-922
174. Bermudez, O. et al. (2013) Gli1 mediates lung cancer cell proliferation and Sonic Hedgehogdependent mesenchymal cell activation. PLoS ONE 8, e63226
175. Chen, X. et al. (2007) Hedgehog signal pathway is activatedinovariancarcinomas, correlatingwithcell proliferation: it's inhibition leads to growth suppression and apoptosis.Cancer Science 98, 68-76
176. Bhattacharya, R. et al. (2008) Role of hedgehog signaling in ovarian cancer. Clinical Cancer Research 14, 7659-7666
177. Schmid, S. et al. (2011) Wnt and hedgehog gene pathway expression in serous ovarian cancer. International Journal of Gynecologic Cancer 21, 975-980
178. Liao, X. et al. (2009) Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30, 131-140
179. Ciucci, A. et al. (2013) Expression of the gliomaassociated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. PLoS ONE 8, e60145
180. Ray, A. et al. (2011) Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. International Journal of Oncology 39, 797-804
181. Chen, Q. et al. (2014) Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin beta4-mediated FAKsignaling. PLoSONE 9, e88386
182. Chen, Y., Bieber, M.M. and Teng, N.N. (2014) Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer. Molecular Carcinogenesis 53, 625-634
183. Sengupta, A. et al. (2007) Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 21, 949-955
184. Kobune, M. et al. (2009) Drug resistance is dramatically restored by hedgehog inhibitors in CD34+leukemic cells. Cancer Science 100, 948-955
185. Desch, P. et al. (2010) Inhibition of GLI, but not Smoothened, induces apoptosis in chroniclymphocytic leukemia cells. Oncogene 29, 4885-4895
186. Greaves, W.O. et al. (2011) Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Human Pathology 42, 1643-1652
187. Singh, R.R. et al. (2010) Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 24, 1025-1036
188. Singh, R.R. et al. (2009) Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Research 69, 2550-2558
189. Riobo, N.A. et al. (2006) Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proceedings of the National Academy of Sciences of the United States of America 103, 4505-4510
190. Ju, B. et al. (2009) Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Molecular Cancer 8, 40
191. Paul, P. et al. (2013) Gli1 transcriptional activity is negatively regulated by AKT2 in neuroblastoma. Oncotarget 4, 1149-1157
192. Ji, Z. et al. (2007) Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. Journal of Biological Chemistry 282, 14048-14055
193. Pasca di Magliano, M. et al. (2006) Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes & Development 20, 3161-3173
194. Nolan-Stevaux, O. et al. (2009) GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes & Development 23, 24-36
195. Lauth, M. et al. (2010) DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nature Structural & Molecular Biology 17, 718-725
196. Riobo, N.A., Haines, G.M. and Emerson, C.P., Jr (2006) Protein kinase C-delta and mitogenactivated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Research 66, 839-845
197. Voronova, A. et al. (2012) Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro. Nucleic Acids Research 40, 3329-3347
198. Whisenant, T.C. et al. (2010) Computational prediction and experimental verification of new MAPkinase docking sites and substrates including Gli transcription factors. PLoS Computational Biology 6, e1000908
199. Kasper, M. et al. (2006) Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Molecular and Cellular Biology 26, 6283-6298
200. Schnidar, H. et al. (2009) Epidermal growth factor receptorsignalingsynergizeswithHedgehog/GLIin oncogenic transformationvia activationof theMEK/ ERK/JUN pathway. Cancer Research 69, 1284-1292
201. Eberl, M. et al. (2012) Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumourinitiating pancreatic cancer cells. EMBO Molecular Medicine 4, 218-233
202. Cai, Q. et al. (2009) Protein kinase Cdelta negatively regulates hedgehog signaling by inhibition of Gli1 activity. Journal of Biological Chemistry 284, 2150-2158
203. Shi, S. et al. (2012)RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway. Journal of Biological Chemistry 287, 7845-7858
204. Hillman, R.T. et al. (2011) Neuropilins are positive regulators of Hedgehog signal transduction. Genes & Development 25, 2333-2346
205. Nakamura, I. et al. (2013) Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration. Journal of Biological Chemistry 288, 21389-21398
206. Zwerner, J.P. et al. (2008) The EWS/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene 27, 3282-3291
207. Beauchamp, E. et al. (2009) GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. Journal of Biological Chemistry 284, 9074-9082
208. Dennler, S. et al. (2007) Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Research 67, 6981-6986
209. Gao, J. et al. (2013) A feedback regulation between Kindlin-2 and GLI1 in prostate cancer cells. FEBS Letters 587, 631-638
210. Kameda, C. et al. (2010) Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer. British Journal of Cancer 102, 738-747
211. Kasperczyk, H. et al. (2009) Characterization of sonic hedgehog as a novel NF-kappaB target genethat promotes NF-kappaB-mediated apoptosis resistance and tumor growth in vivo. The FASEB Journal 23, 21-33
212. Nakashima, H. et al. (2006) Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Research 66, 7041-7049
213. Jia, H. et al. (2009) PP4 and PP2A regulate Hedgehog signaling by controlling Smo and Ci phosphorylation. Development 136, 307-316
214. Doucette, T.A. et al. (2012) WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma. Neurosurgery 70, 1003-1010
215. Pandolfi, S. et al. (2013) WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function. Oncogene 32, 4737-4747
216. Stecca, B. and Ruiz I Altaba, A. (2009) A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO Journal 28, 663-676
217. Abe, Y. et al. (2008) Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proceedings of the National Academy of Sciences of the United States of America 105, 4838-4843
218. Schreck, K.C. et al. (2010) The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clinical Cancer Research 16, 6060-6070
219. Zhuang, Z. et al. (2013) LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway. PLoS ONE 8, e67431
220. Gurung, B. et al. (2013) Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome. Cancer Research 73, 2650-2658
221. Ferretti, E. et al. (2008) Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO Journal 27, 2616-2627
222. Fareh, M. et al. (2012) The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death and Differentiation 19, 232-244
223. Keeler, R.F. (1975) Teratogenic effects of cyclopamine and jervine in rats, mice and hamsters. Proceedings of the Society for Experimental Biology and Medicine 149, 302-306
224. Incardona, J.P. et al. (1998) The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125, 3553-3562
225. Cooper, M.K. et al. (1998) Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280, 1603-1607
226. Athar, M. et al. (2004) Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Research 64, 7545-7552
227. Sanchez, P. and Ruiz i Altaba, A. (2005) In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Mechanisms of Development 122, 223-230
228. Berman, D.M. et al. (2002) Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297, 1559-1561
229. Taipale, J. et al. (2000) Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005-1009
230. Tremblay, M.R. et al. (2009) Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926). Journal of Medicinal Chemistry 52, 4400-4418
231. Amakye, D., Jagani, Z. and Dorsch, M. (2013) Unraveling the therapeutic potential of the Hedgehog pathway in cancer.Nature Medicine 19, 1410-1422
232. Williams, R. (2013) Discontinued drugs in 2012: oncology drugs. Expert Opinion on Investigational Drugs 22, 1627-1644
233. Williams, R. (2015) Discontinued in 2013: oncology drugs. Expert Opinion on Investigational Drugs 24, 95-110
234. Williams, J.A. et al. (2003) Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects onbasal cell carcinoma-like lesions. Proceedings of the National Academy of Sciences of the United States of America 100, 4616-4621
235. Romer, J.T. et al. (2004) Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 6, 229-240
236. Bijlsma, M.F. et al. (2006) Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biology 4, e232
237. Chen, J.K. et al. (2002) Small molecule modulation of Smoothened activity. Proceedings of the National Academy of Sciences of the United States of America 99, 14071-14076
238. Yang, H. et al. (2009) Converse conformational control of smoothened activity by structurally related small molecules. Journal of Biological Chemistry 284, 20876-20884
239. Dijkgraaf, G.J. et al. (2011) Small molecule inhibition of GDC-0449 refractory smoothenedmutants and downstream mechanisms of drug resistance. Cancer Research 71, 435-444
240. Guerlet, G. et al. (2011) Synthesis and biological evaluation of desmethylveramiline, a micromolar Hedgehog inhibitor. Bioorganic & Medicinal Chemistry Letters 21, 3608-3612
241. Wang, Y. et al. (2012) Glucocorticoid compounds modify smoothened localization and hedgehog pathway activity. Chemistry & Biology 19, 972-982
242. Kim, J. et al. (2010) Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 17, 388-399
243. Kim, J. et al. (2013) Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell 23, 23-34
244. Tang, J.Y. et al. (2012) Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. The New England Journal of Medicine 366, 2180-2188
245. Von Hoff, D.D. et al. (2009) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. The New England Journal of Medicine 361, 1164-1172
246. LoRusso, P.M. et al. (2011) Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clinical Cancer Research 17, 2502-2511
247. Sekulic, A. et al. (2012) Efficacy and safety of vismodegib in advanced basal-cell carcinoma. The New England Journal of Medicine 366, 2171-2179
248. Rodon, J. et al. (2014) A phase I, multicenter, openlabel, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors. Clinical Cancer Research 20, 1900-1909
249. Kaye, S.B. et al. (2012) A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remission. Clinical Cancer Research 18, 6509-6518
250. Italiano, A. et al. (2013) GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study. Annals of Oncology 24, 2922-2926
251. Gajjar, A. et al. (2013) Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clinical Cancer Research 19, 6305-6312
252. Shou, Y. et al. (2014) A five-gene hedgehog signature developed as a patient preselection tool for Hedgehog inhibitor therapy in medulloblastoma. Clinical Cancer Research doi:10.1158/1078-0432.CCR-13-1711
253. Yauch, R.L. et al. (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326, 572-574
254. Buonamici, S. et al. (2010) Interfering with resistance to smoothened antagonists by inhibition of the PI3 K pathway in medulloblastoma. Science Translational Medicine 2, 51-70
255. Lee, M.J. et al. (2012) Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model. Proceedings of the National Academy of Sciences of the United States of America 109, 7859-7864
256. Hall, J.M., Bell, M.L. and Finger, T.E. (2003) Disruption of sonic hedgehog signaling alters growth and patterning of lingual taste papillae. Developmental Biology 255, 263-277
257. St-Jacques, B. et al. (1998) Sonic hedgehog signaling is essential for hair development. Current Biology 8, 1058-1068
258. Ramalho-Santos, M., Melton, D.A. and McMahon, A.P. (2000) Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 127, 2763-2772
259. Skvara, H. et al. (2011) Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. Journal of Investigative Dermatology 131, 1735-1744
260. Ericson, J. et al. (1996) Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 87, 661-673
261. Michaud, N.R. et al. (2014) Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling. Molecular Cancer Therapeutics 13, 386-398
262. Stanton, B.Z. et al. (2009) A small molecule that binds Hedgehog and blocks its signaling in human cells. Nature Chemical Biology 5, 154-156
263. Petrova, E. et al. (2013) Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling. Nature Chemical Biology 9, 247-249
264. Lauth, M. et al. (2007) Inhibition of GLI-mediated transcription and tumor cell growth by smallmolecule antagonists. Proceedings of the National Academy of Sciences of the United States of America 104, 8455-8460
265. Hosoya, T. et al. (2008) Naturally occurring smallmolecule inhibitors of hedgehog/GLI-mediated transcription. Chembiochem 9, 1082-1092
266. Hyman, J.M. et al. (2009) Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proceedings of the National Academy of Sciences of the United States of America 106, 14132-14137
267. Kim, J. et al. (2010) Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proceedings of the National Academy of Sciences of the United States of America 107, 13432-13437
268. Beauchamp, E.M. et al. (2011) Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. The Journal of Clinical Investigation 121, 148-160
269. Li, B. et al. (2014) Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis. PLoS ONE 9, e101969
270. Infante, P. et al. (2015) Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. EMBO Journal 34, 200-217
271. Tang, Y. et al. (2014) Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature Medicine 20, 732-740
272. Pan, Y., Wang, C. and Wang, B. (2009) Phosphorylation of Gli2 by protein kinase A is required for Gli2 processing and degradation and the Sonic Hedgehog-regulated mouse development. Developmental Biology 326, 177-189
273. Lacarrubba, F. et al. (2011) Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review. Journal of Dermatological Treatment 22, 353-358
274. Wolff, F. et al. (2013) Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation. Oncogene 32, 5574-5581
275. Jinawath, A. et al. (2007) Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells. Journal of Cancer Research and Clinical Oncology 133, 271-278
276. Chitkara, D. et al. (2012) Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer. Molecular Pharmaceutics 9, 2350-2357
277. Mimeault, M. et al. (2007) Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Molecular Cancer Therapeutics 6, 967-978
278. Eimer, S. et al. (2012) Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures. Neuro-Oncology 14, 1441-1451
279. Keysar, S.B. et al. (2013) Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer. Cancer Research 73, 3381-3392
280. Gruber Filbin, M. et al. (2013) Coordinate activation of Shh and PI3 K signaling in PTENdeficient glioblastoma: new therapeutic opportunities. Nature Medicine 19, 1518-1523
281. Mueller, M.T. et al. (2009) Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 137, 1102-1113
282. Hermann, P.C. et al. (2013) Multimodal treatment eliminates cancer stem cells and leads to long-term survival in primary human pancreatic cancer tissue xenografts. PLoS ONE 8, e66371
283. Okuhashi, Y. et al. (2011) Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells. AntiCancer Research 31, 893-896
284. Ulasov, I.V. et al. (2011) Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Molecular Medicine 17, 103-112
285. Domingo-Domenech, J. et al. (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch-and hedgehogdependent tumor-initiating cells. Cancer Cell 22, 373-388
286. Chomel, J.C. and Turhan, A.G. (2011) Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy. Oncotarget 2, 713-727
287. Liao, H.F. et al. (2012) Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells. Biomedicine & Pharmacotherapy 66, 378-383
288. Okabe, S. et al. (2012) Effects of the hedgehog inhibitor GDC-0449, alone or in combination with dasatinib, on BCR-ABL-positive leukemia cells. Stem Cells and Development 21, 2939-2948
289. Katagiri, S. et al. (2013) Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia. Clinical Cancer Research 19, 1422-1432
290. Ferruzzi, P. et al. (2012) In vitro and in vivo characterization of a novel Hedgehog signalingantagonist in human glioblastoma cell lines. International Journal of Cancer 131, E33-E44
291. Lens, S.M., Voest, E.E. and Medema, R.H. (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nature Reviews Cancer 10, 825-841
292. Markant, S.L. et al. (2013) Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases. Cancer Research 73, 6310-6322
293. Castellino, R.C. et al. (2008) Medulloblastomas overexpress the p53-inactivating oncogene WIP1/ PPM1D. Journal of Neuro-Oncology 86, 245-256
294. Buss, M.C. et al. (2014) The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants. Oncogene doi:10.1038/ onc.2014.37
295. Liang, C. et al. (2012) Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas. Brain Research 1444, 65-75
296. Lu, X., Nannenga, B. and Donehower, L.A. (2005) PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes & Development 19, 1162-1174
297. Lu, M. et al. (2013) Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. Cancer Cell 23, 618-633
298. Berlin, J. et al. (2013) A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer. Clinical Cancer Research 19, 258-267
299. Kim, E.J. et al. (2014) Pilot clinical trial of Hedgehog pathway inhibitor GDC-0449 (Vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma. Clinical Cancer Research 20, 5937-5945
300. Wagner, A.J. et al. (2014) A phase I study of PF-04449913, an oral Hedgehog inhibitor, in patients with advanced solid tumors. Clinical Cancer Research doi:10.1158/1078-0432.CCR-14-111.